These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8453319)

  • 21. Modulation of calcium oxalate monohydrate crystallization kinetics in vitro.
    Kok DJ; Papapoulos SE; Blomen LJ; Bijvoet OL
    Kidney Int; 1988 Sep; 34(3):346-50. PubMed ID: 2459439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mineralogical composition of urinary stones, risk factors and metabolic disturbances in patients with calcium-oxalate urolithiasis].
    Kustov AV; Strelnikov AI; Moryganov MA; Airapetyan AO; Smirnov PR; Lyalyakina EV; Toms SR
    Urologiia; 2017 Sep; (4):22-26. PubMed ID: 28952687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
    Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM
    Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of citrate and urine on calcium oxalate crystal aggregation.
    Tiselius HG; Fornander AM; Nilsson MA
    Urol Res; 1993; 21(5):363-6. PubMed ID: 8279094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of crystal growth of calcium oxalate in gel and its modification by urinary constituents in a new flow model of crystallization.
    Achilles W; Freitag R; Kiss B; Riedmiller H
    J Urol; 1995 Oct; 154(4):1552-6. PubMed ID: 7658589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stone prevention: why so little progress?
    Baumann JM
    Urol Res; 1998; 26(2):77-81. PubMed ID: 9631938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concentrated urine and diluted urine: the effects of citrate and magnesium on the crystallization of calcium oxalate induced in vitro by an oxalate load.
    Guerra A; Meschi T; Allegri F; Prati B; Nouvenne A; Fiaccadori E; Borghi L
    Urol Res; 2006 Dec; 34(6):359-64. PubMed ID: 16953377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The in-vivo effect of sodium-potassium citrate on the crystal growth rate of calcium oxalate and other parameters in human urine.
    Achilles W; Schulze D; Schalk C; Rodeck G
    Urol Res; 1990; 18(1):1-6. PubMed ID: 2316065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in calcium stone formers.
    Fuselier HA; Moore K; Lindberg J; Husserl FE; Cole FE; Kok DJ; Whitehead D; Galliano DJ; Erwin DT
    Urology; 1998 Dec; 52(6):988-94. PubMed ID: 9836542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of magnesium on calcium oxalate urolithiasis.
    Su CJ; Shevock PN; Khan SR; Hackett RL
    J Urol; 1991 May; 145(5):1092-5. PubMed ID: 2016799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspects of calcium oxalate crystallization: theory, in vitro studies, and in vivo implementation.
    Rodgers A
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S351-4. PubMed ID: 10541262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idiopathic calcium oxalate urinary lithiasis: usefulness of Parks' and Tiselius' indices in the evaluation of the risk of stone formation.
    Robert M; Roux JO; Boularan AM; Bourelly F; Monnier L; Grasset D
    Urol Int; 1995; 55(2):88-92. PubMed ID: 8533202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic disturbances in Chinese children with urolithiasis: a single center report.
    Yang D; Tiselius HG; Lan C; Chen D; Chen K; Ou L; Liu Y; Xu S; Zeng G; Lei M; Wu W
    Urolithiasis; 2017 Jun; 45(3):285-290. PubMed ID: 27510800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of agglomeration in the early stages of papillar stone formation.
    Söhnel O; Grases F; Garcia-Ferragut L
    Scanning Microsc; 1994; 8(3):513-21; discussion 521-2. PubMed ID: 7747153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium citrate: reduced propensity for the crystallization of calcium oxalate in urine resulting from induced hypercalciuria of calcium supplementation.
    Harvey JA; Zobitz MM; Pak CY
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1223-5. PubMed ID: 4055988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
    Hassani MA; Hennequin C; Lacour B; Daudon M
    Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of different food forms on the urine composition and the risk of calcium oxalate stone formation].
    Siener R; Hesse A
    Z Ernahrungswiss; 1993 Mar; 32(1):46-55. PubMed ID: 8484269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Urinary citrate excretion in children with calcium urolithiasis].
    Sikora P; Bieniaś B; Majewski M; Borzecka H; Wawrzyszuk M; Zajaczkowska M
    Przegl Lek; 2006; 63 Suppl 3():134-6. PubMed ID: 16898511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new approach to studying inhibitors of calcium oxalate crystal growth.
    Hennequin C; Lalanne V; Daudon M; Lacour B; Drueke T
    Urol Res; 1993 Mar; 21(2):101-8. PubMed ID: 8389069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.